All AstraZeneca articles
-
Features
How Carillion managed ‘year-long’ longevity swap project
Carillion improved its governance and data to ensure a good deal on its £1bn longevity swap, as it sought to hedge greater-than-anticipated life expectancy among members of its defined benefit schemes.